Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 4 | 2022 | 622 | 0.380 |
Why?
|
| Blood Coagulation Disorders | 2 | 2023 | 100 | 0.370 |
Why?
|
| Hemorrhage | 4 | 2022 | 459 | 0.350 |
Why?
|
| Hemostasis | 2 | 2019 | 69 | 0.310 |
Why?
|
| Recombinant Proteins | 4 | 2024 | 1390 | 0.290 |
Why?
|
| Hirudins | 3 | 2022 | 37 | 0.270 |
Why?
|
| Thrombosis | 2 | 2022 | 519 | 0.260 |
Why?
|
| Anticoagulants | 5 | 2022 | 583 | 0.260 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2021 | 29 | 0.230 |
Why?
|
| ADAMTS13 Protein | 1 | 2024 | 62 | 0.230 |
Why?
|
| Erythrocyte Transfusion | 2 | 2022 | 121 | 0.230 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 54 | 0.220 |
Why?
|
| Factor VIII | 2 | 2020 | 44 | 0.220 |
Why?
|
| Thrombelastography | 2 | 2021 | 55 | 0.210 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 53 | 0.210 |
Why?
|
| Antifibrinolytic Agents | 1 | 2022 | 33 | 0.200 |
Why?
|
| Hip Dislocation | 1 | 2022 | 27 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 172 | 0.190 |
Why?
|
| Heart-Assist Devices | 2 | 2022 | 1023 | 0.190 |
Why?
|
| Kasabach-Merritt Syndrome | 1 | 2020 | 16 | 0.180 |
Why?
|
| Thrombophilia | 1 | 2020 | 40 | 0.180 |
Why?
|
| Heparitin Sulfate | 1 | 2020 | 20 | 0.180 |
Why?
|
| Blood Coagulation | 1 | 2021 | 119 | 0.170 |
Why?
|
| Anesthetics | 1 | 2020 | 81 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2024 | 547 | 0.170 |
Why?
|
| Liver Failure | 1 | 2020 | 89 | 0.170 |
Why?
|
| Heparin | 4 | 2022 | 227 | 0.160 |
Why?
|
| Anemia | 1 | 2022 | 339 | 0.150 |
Why?
|
| Blood Group Incompatibility | 1 | 2018 | 27 | 0.150 |
Why?
|
| ABO Blood-Group System | 1 | 2018 | 65 | 0.150 |
Why?
|
| Child | 13 | 2024 | 24221 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 334 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 406 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 390 | 0.140 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 342 | 0.140 |
Why?
|
| Blood Transfusion | 3 | 2022 | 302 | 0.130 |
Why?
|
| Peptide Fragments | 3 | 2022 | 748 | 0.110 |
Why?
|
| Humans | 19 | 2024 | 123146 | 0.100 |
Why?
|
| Platelet Transfusion | 2 | 2022 | 53 | 0.090 |
Why?
|
| Partial Thromboplastin Time | 2 | 2021 | 45 | 0.090 |
Why?
|
| Plasma | 2 | 2022 | 96 | 0.090 |
Why?
|
| Blood Coagulation Tests | 2 | 2021 | 60 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1013 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2023 | 16000 | 0.080 |
Why?
|
| Pregnancy | 3 | 2024 | 7142 | 0.060 |
Why?
|
| Infant | 4 | 2022 | 12339 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2022 | 8104 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2022 | 13878 | 0.060 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 35 | 0.060 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 32 | 0.050 |
Why?
|
| Acute Chest Syndrome | 1 | 2021 | 9 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 29029 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 55 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12116 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2022 | 146 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 264 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 118 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 300 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 33 | 0.050 |
Why?
|
| Female | 6 | 2024 | 65443 | 0.040 |
Why?
|
| Hemostatics | 1 | 2019 | 57 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2022 | 1243 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2019 | 150 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 771 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2018 | 236 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 1134 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2018 | 582 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1149 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 644 | 0.030 |
Why?
|
| Stroke | 1 | 2021 | 958 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3380 | 0.020 |
Why?
|
| Adolescent | 2 | 2022 | 19093 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6205 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6027 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5046 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10011 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 8864 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3011 | 0.020 |
Why?
|
| Male | 2 | 2018 | 60034 | 0.010 |
Why?
|